EX-16.1 2 ex16-1.htm EXHIBIT 16.1 Exhibit 16.1
Exhibit 16.1
Form 8-K/A
Immunotechnology Corporation
File No. 0-24641


October 4, 2005

Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549

Ladies and Gentlemen:

We have read the statements of Immunotechnology Corporation pertaining to our firm included under Item 4.01 of Form 8-K/A dated October 4, 2005 and agree with such statements as they pertain to our firm. We have no basis to agree or disagree with other statements of the registrant contained therein.

Sincerely,



/s/ HJ & Associates, LLC